Table S1. Characteristics of 44 breast cancer patients with neoadjuvant chemotherapy. Figure S1. The MTDH mRNA and protein expressions level in different groups after transfecting. We constructed four groups of shRNA and one control shRNA. Then we selected the optimal silent shRNA via real-time PCR and western blot. Figure S2. Annexin V-PE/7-AAD assay for determination of apoptosis of cells overexpressing or knocking down metadherin (MTDH) with a flow cytometer. Annexin-positive cells are presented in gate 4. Figure S3. Annexin V-PE/7-AAD assay for the determination of apoptosis of different cells after paclitaxel (TAX) treatment. The apoptosis rate of MCF-7–metadherin–short hairpin RNA (MCF-7–MTDH–shRNA) cells was significantly enhanced. F...
MTS, migration and invasion assays in DCIS.COM cells that were previously transduced with scrambled ...
Table S1. Antibodies used in this study. Table S2. Origins and genetic aberrations of mucosal melano...
Figure S3. Combinatory treatment with HER3 siRNA and trastuzumab is useful for overcoming trastuzuma...
Figure S1 Generation of a murine EMT6-hHER2 breast cancer cell line. A, Human-HER2 expression in EMT...
Figure S1. TSLNR expression in breast cancer samples and normal tissue samples in HMUCC. Figure S2. ...
Figure S2. ED and EAD induce cell growth arrest. (A) qRT-PCR of cyclin D1 (CCND1) and cyclin-depende...
Lenalidomide induced cell death is a slow process. Cell survival was monitored by MTT assay. Figure ...
Figure S1. Gene expression array profile of TNBC cells identified entinostat and doxorubicin (ED) as...
MEDI3039 induces cell death in TNBC cell lines. (A) Western blot showing time-dependent effect of ME...
Figure S6. Assessment of dynamic changes in gene expression in response to RAD001, neratinib, or the...
Figure S1. In vitro cell viability of MDA-MB-231, LM2–4, EMT-6 and EMT-6/CDDP cell lines when treate...
Figure S3. Effect of 14 single genes on pathological complete response (pCR) adjusting for clinicopa...
Table S2. Rates of pathological complete response (pCR) reported across 15 published neoadjuvant cli...
Figure S1. A. MTS assay was performed and plotted for the cell proliferation of shcon and shTPD54 ce...
This file contains the following: Table S1: a table with FISH data of TOP1/CEN-20 and TOP2A/CEN-17, ...
MTS, migration and invasion assays in DCIS.COM cells that were previously transduced with scrambled ...
Table S1. Antibodies used in this study. Table S2. Origins and genetic aberrations of mucosal melano...
Figure S3. Combinatory treatment with HER3 siRNA and trastuzumab is useful for overcoming trastuzuma...
Figure S1 Generation of a murine EMT6-hHER2 breast cancer cell line. A, Human-HER2 expression in EMT...
Figure S1. TSLNR expression in breast cancer samples and normal tissue samples in HMUCC. Figure S2. ...
Figure S2. ED and EAD induce cell growth arrest. (A) qRT-PCR of cyclin D1 (CCND1) and cyclin-depende...
Lenalidomide induced cell death is a slow process. Cell survival was monitored by MTT assay. Figure ...
Figure S1. Gene expression array profile of TNBC cells identified entinostat and doxorubicin (ED) as...
MEDI3039 induces cell death in TNBC cell lines. (A) Western blot showing time-dependent effect of ME...
Figure S6. Assessment of dynamic changes in gene expression in response to RAD001, neratinib, or the...
Figure S1. In vitro cell viability of MDA-MB-231, LM2–4, EMT-6 and EMT-6/CDDP cell lines when treate...
Figure S3. Effect of 14 single genes on pathological complete response (pCR) adjusting for clinicopa...
Table S2. Rates of pathological complete response (pCR) reported across 15 published neoadjuvant cli...
Figure S1. A. MTS assay was performed and plotted for the cell proliferation of shcon and shTPD54 ce...
This file contains the following: Table S1: a table with FISH data of TOP1/CEN-20 and TOP2A/CEN-17, ...
MTS, migration and invasion assays in DCIS.COM cells that were previously transduced with scrambled ...
Table S1. Antibodies used in this study. Table S2. Origins and genetic aberrations of mucosal melano...
Figure S3. Combinatory treatment with HER3 siRNA and trastuzumab is useful for overcoming trastuzuma...